| SANZESA MERCK KGAA
1739731 30 Jul 2015 | on 05 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely, preparations for the treatment of immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, neurological diseases and disorders, namely, multiple sclerosis, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders | | | SANZESA MERCK KGAA
1458042 05 Nov 2009 | on 26 Jan 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely preparations for the treatment of immunological diseases and disorders namely, auto-immune diseases, immunologic deficiency syndromes, autoimmune connective tissue diseases, inflammatory diseases and disorders, namely inflammatory connective tissue diseases, endocrinological diseases and disorders, namely growth disorders, oncological diseases and disorders, neurological diseases and disorders, namely preparations for use in treating multiple sclerosis, parkinsons, infertility diseases and disorders, metabolic diseases and disorders, namely, phenylketonuria (pku), growth disorders, rheumatological diseases and disorders. | | | SANZESA ARES TRADING S.A.
1272504 19 Sep 2005 | on 07 Dec 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central and peripheral nervous system, namely, Parkinson's disease, Huntington's disease, Gilles de la Tourette's syndrome, depression, anxiety, cognitive disturbance, restless legs sydrome, myoclonus, tic disorders, movement disorders, levodopa-induced dyskinesia in Parkinson's disease, and tardive dyskinesia induced by neuroleptics. | |